<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>Hematological Cancer News Articles Provided by Cancer Compass</title>
    <description>CancerCompass is dedicated to provided you with the most up to date cancer information and news. Visit our website to find all our articles on Hematological Cancer News</description>
    <link>http://www.cancercompass.com/hematological-cancer-news.htm</link>
    <pubDate>Sat, 21 Nov 2009 00:00:00 GMT</pubDate>
    <lastBuildDate>Sat, 21 Nov 2009 00:00:00 GMT</lastBuildDate>
    <docs>http://backend.userland.com/rss</docs>
    <generator>RSS.NET: http://www.rssdotnet.com/</generator>
    <item>
      <title>Synta Presents Preclinical Data On Next Generation Hsp90 Inhibitor, STA-9090</title>
      <description>Synta Pharmaceuticals Corp, a  biopharmaceutical company focused on  discovering, developing, and commercializing  small molecule drugs to treat severe medical  conditions, today announced that preclinical  data presented at the AACR-NCI-EORTC Conference  on Molecular Targets and Cancer Therapeutics  shows that STA-9090, a novel, synthetic  inhibitor of heat shock protein 90 (Hsp90),  demonstrated strong activity in multiple tumor  models.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32436.htm</link>
      <author>CancerCompass</author>
      <pubDate>Thu, 19 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Cancer Survivor Ready for Next Challenge: Off-Road Racing's Baja 1000</title>
      <description>Joe Bacal survived Hodgkin's lymphoma and now he takes on the Baja 1000 - a 675-mile off-road race through the Mexican desert. Bacal hopes to inspire other cancer patients to take control of their cancer care. </description>
      <link>http://www.cancercompass.com/cancer-news/article/32435.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Lifestyle Could Reduce Cancer Two-Thirds</title>
      <description>U.S. health experts say about two-thirds of  cancers could be prevented via lifestyle  changes. The Mayo Clinic researchers explain in  their Special Report on Cancer Prevention in the  November issue of Mayo Clinic Women's  HealthSource says maintaining proper weight by  eating a healthy, low-fat diet and by stepping  up moderate to vigorous physical activity to 45  to 60 minutes almost daily might reduce one- third of cancer deaths.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32421.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Medical Patients Drawn To Internet When Managing Own Health</title>
      <description>When the pain in her knee from an old running  injury continued even after surgery, Sarah  McCluan turned to the Internet for help. I don't  use it to diagnose ,but I do go to the Internet  for basic information," said McCluan, who  downloaded some knee strengthening exercises  that she is following. McCluan, 37, of Hopewell  is among a growing number of wired adults  searching the Internet for medical information.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32422.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Studies From Northwestern University, Medical Department Yield New Data On Myeloma</title>
      <description>Multiple myeloma, an incurable plasma cell  malignancy, is characterized by altered cellular  metabolism and resistance to apoptosis. Recent  connections between glucose metabolism and  resistance to apoptosis provide a compelling  rationale for targeting metabolic changes in  cancer, scientists in the United States report.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32409.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Researchers From Harvard University Report Recent Findings In Cancer</title>
      <description>Several components of the Writ signaling cascade  have been shown to function either as tumor  suppressor proteins or as oncogenes in multiple  human cancers, underscoring the relevance of  this pathway in oncogenesis and the need for  further investigation of Wnt signaling  components as potential targets for cancer  therapy.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32411.htm</link>
      <author>CancerCompass</author>
      <pubDate>Sat, 14 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Research On Brain Metastasis Detailed By Scientists At University Of Pittsburgh</title>
      <description>According to recent research from the United  States, Radiosurgery for brain metastasis fails  in some patients, who require further surgical  care. In this paper the authors' goal was to  evaluate prognostic factors that correlate with  the survival of patients who require a resection  of a brain metastasis after stereotactic  radiosurgery (SRS).</description>
      <link>http://www.cancercompass.com/cancer-news/article/32433.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Study Shows MabThera Maintenance Treatment Delays Disease Progression In Patients With Incurable Lymphoma</title>
      <description>Roche announced results from the international  phase III study PRIMA1, which show that MabThera  (rituximab) maintenance therapy can  significantly increase the time until the  disease progresses in newly-treated patients  with advanced follicular lymphoma, a common and  slow-developing but incurable form of lymphoma.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32441.htm</link>
      <author>CancerCompass</author>
      <pubDate>Thu, 19 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>NCCN Receives Research Grant To Evaluate Pralatrexate In Solid Tumors And Hematologic Malignancies</title>
      <description>NCCN recently received a research grant from  Allos Therapeutics, Inc. to evaluate the role of  pralatrexate in the treatment of select  hematologic malignancies and solid tumors.  Pralatrexate is the only agent currently  approved by the FDA to treat patients with  relapsed or refractory peripheral T-cell  lymphoma. Investigators from NCCN Member  Institutions are eligible to apply for the  research funding.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32382.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 10 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Genmab Announces Start Of Ofatumumab Phase III Head To Head Study In DLBCL</title>
      <description>Genmab A/S announced today the initiation of a  Phase III study of Arzerra (TM) ofatumumab plus  chemotherapy versus rituximab plus chemotherapy  to treat patients with relapsed or refractory  diffuse large B-cell lymphoma (DLBCL).</description>
      <link>http://www.cancercompass.com/cancer-news/article/32383.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 10 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Study Offers More Evidence To Green Tea's Anti-Cancer Effect</title>
      <description>A new U.S. study has shown that green tea may  help reduce the risk of oral cancer, although  scientists are reluctant to officially endorse  green tea as an effective way of cancer  prevention.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32387.htm</link>
      <author>CancerCompass</author>
      <pubDate>Tue, 10 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Antipsychotic Drugs Fight Cancer</title>
      <description>Drugs used to treat psychiatric disorders are  highly effective at killing cancer cells,  opening up potential new lines of treatments. Dr  Louise Lurze-Mann of the University of NSW  School of Biotechnology and Biomolecular  Sciences was talking with psychiatric  researchers at the University of Queensland when  they mentioned that people with diseases like  schizophrenia appear to have low rates of  cancer, despite being more inclined to smoke  than the general population.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32367.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Sweet Potatoes Make For A Hearty Soup Base</title>
      <description>It's a safe bet to presume there are soup recipes in today's column because it's colder, furnaces are running and it just seems like a fall thing to do. </description>
      <link>http://www.cancercompass.com/cancer-news/article/32365.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Newly Found Molecule Disrupts Cancer Cells</title>
      <description>U.S. scientists say they have discovered a small  molecule that inhibits the actions of a protein  cancer cells require for survival. The  researchers said they determined the molecule,  called PES, inhibits a type of protein called a  heat-shock protein that helps cells survive  heat, lack of nutrients and other cell-damaging  conditions.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32368.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Alternatively Spliced Tissue Factor Identified As Promising New Biomarker For Aggressive Cancers</title>
      <description>A recently discovered form of the protein that  triggers blood clotting may play a key role in  the molecular mechanisms leading to the growth  of certain metastatic cancers, according to new  research reported by an international team of  scientists.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32371.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>FDA Approves Gloucester Pharmaceuticals' ISTODAX For Patients With Cutaneous T-cell Lymphoma</title>
      <description>Gloucester Pharmaceuticals announced today that  the U.S. Food and Drug Administration (FDA)  approved ISTODAX(R) (romidepsin) for the  treatment of cutaneous T-cell lymphoma (CTCL) in  patients who have received at least one prior  systemic therapy.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32376.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Exercise Is Good Medicine For Lymphoma Patients</title>
      <description>The Healthy Exercise for Lymphoma Patients  (HELP) trial, a three-year study led by Kerry  Courneya, Canada Research Chair in physical  activity and cancer in the Faculty of Physical  Education and Recreation, found that a regimen  of aerobic exercise training produced  significant improvements in physical functioning  and overall quality of life benefits in patients  with lymphoma.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32378.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Scientists Discuss Research In Neutropenia</title>
      <description>According to recent research from the United  States, Bacterial infection is the most common  complication of chemotherapy-induced neutropenia  particularly in patients with hematologic  malignancies. Bacterial infections predominate  during the initial phases of neutropenic  episodes.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32379.htm</link>
      <author>CancerCompass</author>
      <pubDate>Fri, 06 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Stuffed Acorn Squash Makes A Hearty Entree</title>
      <description>Mollie Katzen's latest cookbook urges beginners  to take on her challenge with easy recipes, such  as this acorn squash entree. Use plain raw  almonds, not roasted or salted, Katzen writes,  and don't chop them too fine.  You can cook the rice and bake the acorn squash  at the same time.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32356.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Light Stews Still Hearty: Reduce Fat And Salt In Fall Soups</title>
      <description>If you're watching your weight, soup can be  deceptive. What could be more harmless for lunch  or a light dinner? Not so fast. Depending on the  recipe, some soups are full of cream and cheese,  or sometimes worse, they start with a roux. In  place of cream and butter, add flavor to soup  with lots of vegetables, beef broth and dried  and fresh herbs.</description>
      <link>http://www.cancercompass.com/cancer-news/article/32357.htm</link>
      <author>CancerCompass</author>
      <pubDate>Wed, 04 Nov 2009 00:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>